Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
Journal of Immunological Methods
|
November 5, 1992
Antibodies to soluble human T cell receptor beta chain recognize multiple epitopes on cell surface TcR
G S Basi, M B Riggs, K Nash, et al.
Controlled Clinical Trials
|
July 31, 1998
Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics
D Grady, W Applegate, T Bush, et al.
Seminars in Oncology
|
October 9, 2012
Neoadjuvant and adjuvant chemotherapy approaches for invasive bladder cancer
Derek Raghavan, Earle Burgess, Kris E Gaston, et al.
The Oncologist
|
April 11, 2014
Postchemotherapy surgery for germ cell tumors--what have we learned in 35 years?
Stephen B Riggs, Earl F Burgess, Kris E Gaston, et al.
JAMA
|
August 26, 1998
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group
S Hulley, D Grady, T Bush, et al.
Urology
|
January 29, 2013
Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer
Jack W Lambert, Matthew Ingham, Bethany Barone Gibbs, et al.
CA: a Cancer Journal for Clinicians
|
January 1, 1975
Hypercalcemia and cancer
D A Scholz, D C Purnell, R S Goldsmith, et al.
Journal of Applied Microbiology
|
February 22, 2011
Efficacy of liquid spray decontaminants for inactivation of Bacillus anthracis spores on building and outdoor materials
J P Wood, Y W Choi, J V Rogers, et al.
Urologic Oncology
|
November 12, 2025
Protocol-driven same day discharge for robotic radical prostatectomy
Emily H Roebuck, Lila G McGrath, Myra Robinson, et al.
Urology
|
March 26, 2013
Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors
Peter Q Shelton, Allie N Ivanowicz, Carolyn M Wakeman, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
Journal of Immunological Methods
|
November 5, 1992
Antibodies to soluble human T cell receptor beta chain recognize multiple epitopes on cell surface TcR
G S Basi, M B Riggs, K Nash, et al.
Controlled Clinical Trials
|
July 31, 1998
Heart and Estrogen/progestin Replacement Study (HERS): design, methods, and baseline characteristics
D Grady, W Applegate, T Bush, et al.
Seminars in Oncology
|
October 9, 2012
Neoadjuvant and adjuvant chemotherapy approaches for invasive bladder cancer
Derek Raghavan, Earle Burgess, Kris E Gaston, et al.
The Oncologist
|
April 11, 2014
Postchemotherapy surgery for germ cell tumors--what have we learned in 35 years?
Stephen B Riggs, Earl F Burgess, Kris E Gaston, et al.
JAMA
|
August 26, 1998
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group
S Hulley, D Grady, T Bush, et al.
Urology
|
January 29, 2013
Using preoperative albumin levels as a surrogate marker for outcomes after radical cystectomy for bladder cancer
Jack W Lambert, Matthew Ingham, Bethany Barone Gibbs, et al.
CA: a Cancer Journal for Clinicians
|
January 1, 1975
Hypercalcemia and cancer
D A Scholz, D C Purnell, R S Goldsmith, et al.
Journal of Applied Microbiology
|
February 22, 2011
Efficacy of liquid spray decontaminants for inactivation of Bacillus anthracis spores on building and outdoor materials
J P Wood, Y W Choi, J V Rogers, et al.
Urologic Oncology
|
November 12, 2025
Protocol-driven same day discharge for robotic radical prostatectomy
Emily H Roebuck, Lila G McGrath, Myra Robinson, et al.
Urology
|
March 26, 2013
Active surveillance of very-low-risk prostate cancer in the setting of active treatment of benign prostatic hyperplasia with 5α-reductase inhibitors
Peter Q Shelton, Allie N Ivanowicz, Carolyn M Wakeman, et al.
Page
of 7